Deferacirox dispersible tablets

Details for Australian Patent Application No. 2003278078 (hide)

Owner Novartis AG

Inventors Cassiere, Jean-Pierre; Deffez, Karine

Agent Davies Collison Cave

Pub. Number AU-B-2003278078

PCT Number PCT/EP03/11351

PCT Pub. Number WO2004/035026

Priority 0223978.8 15.10.02 GB

Filing date 14 October 2003

Wipo publication date 4 May 2004

Acceptance publication date 2 August 2007

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 39/04 (2006.01) General protective or antinoxious agents

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 0223978.8 15.10.02 GB

10 June 2004 Application Open to Public Inspection

  Published as AU-B-2003278078

2 August 2007 Application Accepted

  Published as AU-B-2003278078

6 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278079-PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS

2003278077-CAM FOLLOWER FOR A VALVE GEAR IN AN INTERNAL COMBUSTION ENGINE